Common Stock, Shares, Outstanding of KALA BIO, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
KALA BIO, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • KALA BIO, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 7,432,925, a 61% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

KALA BIO, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 7,432,925 +2,822,786 +61% 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 6,679,115 +2,080,696 +45% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 6,452,398 +3,635,944 +129% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 6,091,182 +3,331,810 +121% 31 Dec 2024 10-Q 19 Nov 2025 2025 Q3
Q3 2024 4,610,139 +1,917,023 +71% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 4,598,419 +2,059,732 +81% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 2,816,454 +507,167 +22% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 2,759,372 +1,052,401 +62% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 2,693,116 +1,216,479 +82% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 2,538,687 -70,135,098 -97% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 2,309,287 -70,284,718 -97% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 1,706,971 +384,507 +29% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 1,476,637 -63,608,587 -98% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 72,673,785 +7,903,566 +12% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 72,594,005 +8,788,897 +14% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 1,322,464 -57,592,911 -98% 31 Dec 2021 10-K 03 Mar 2023 2022 FY
Q3 2021 65,085,224 +9,023,859 +16% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 64,770,219 +8,939,198 +16% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 63,805,108 +9,219,472 +17% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 58,915,375 +22,829,121 +63% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 56,061,365 +21,517,606 +62% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 55,831,021 +21,948,054 +65% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 54,585,636 +20,702,779 +61% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 36,086,254 +2,223,177 +6.6% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 34,543,759 +9,898,217 +40% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 33,882,967 +9,290,693 +38% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 33,882,857 +9,326,763 +38% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 33,863,077 +9,324,768 +38% 31 Dec 2018 10-K 12 Feb 2020 2019 FY
Q3 2018 24,645,542 +298,392 +1.2% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 24,592,274 +23,410,845 +1982% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 24,556,094 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 24,538,309 +23,356,880 +1977% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q3 2017 24,347,150 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 1,181,429 30 Jun 2017 10-Q 31 Aug 2017 2017 Q2
Q4 2016 1,181,429 31 Dec 2016 10-K 02 Apr 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.